Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
Chao Zhang,Jiesheng Li,Yongqian Cheng,Fanping Meng,Jin-Wen Song,Xing Fan,Hongtao Fan,Jing Li,Yu-Long Fu,Ming-Ju Zhou,Wei Hu,Si-Yu Wang,Yuan-Jie Fu,Ji-Yuan Zhang,Ruo-Nan Xu,Ming Shi,Xueda Hu,Zemin Zhang,Xianwen Ren,Fu-Sheng Wang
DOI: https://doi.org/10.1136/gutjnl-2021-325915
IF: 24.5
2022-03-31
Gut
Abstract:Objective A comprehensive immune landscape for HBV infection is pivotal to achieve HBV cure. Design We performed single-cell RNA sequencing of 2 43 000 cells from 46 paired liver and blood samples of 23 individuals, including six immune tolerant, 5 immune active (IA), 3 acute recovery (AR), 3 chronic resolved and 6 HBV-free healthy controls (HCs). Flow cytometry and histological assays were applied in a second HBV cohort for validation. Results Both IA and AR were characterised by high levels of intrahepatic exhausted CD8+ T (Tex) cells. In IA, Tex cells were mainly derived from liver-resident GZMK+ effector memory T cells and self-expansion. By contrast, peripheral CX3CR1+ effector T cells and GZMK+ effector memory T cells were the main source of Tex cells in AR. In IA but not AR, significant cell–cell interactions were observed between Tex cells and regulatory CD4+ T cells, as well as between Tex and FCGR3A+ macrophages. Such interactions were potentially mediated through human leukocyte antigen class I molecules together with their receptors CANX and LILRBs, respectively, contributing to the dysfunction of antiviral immune responses. By contrast, CX3CR1+GNLY+ central memory CD8+ T cells were concurrently expanded in both liver and blood of AR, providing a potential surrogate marker for viral resolution. In clinic, intrahepatic Tex cells were positively correlated with serum alanine aminotransferase levels and histological grading scores. Conclusion Our study dissects the coordinated immune responses for different HBV infection phases and provides a rich resource for fully understanding immunopathogenesis and developing effective therapeutic strategies.
gastroenterology & hepatology